Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd.


Mylan, Matrix Laboratories, Mylan Laboratories, Robert Coury, active pharmaceutical ingredients, API, pharmaceutical




































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

It's official: Matrix renamed Mylan Laboratories

October 19th, 2011

PITTSBURGH and HYDERABAD, India – Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd.

The name change is effective immediately, the company said. Mylan announced its intention to rebrand Matrix, one of the world's largest manufacturers of active pharmaceutical ingredients (API), as a Mylan company this spring. Matrix

"We are pleased to complete the name change from Matrix to a Mylan company and are excited to operate in India under one powerful brand," Mylan Inc. chairman and chief executive officer Robert Coury said in a statement.

"For the last 50 years, the Mylan name has stood for high-quality products, unmatched reliability, outstanding customer service, unrelenting integrity, continuous innovation and serving unmet needs. Mylan's unwavering commitment to quality and long-standing track record of excellence set us apart from our competitors and will help to ensure our long-term success in India and around the world," he stated. "We look forward to further educating customers, physicians, pharmacists and patients about the Mylan brand as we continue to grow our existing business and launch in the Indian commercial market in the coming months."

Mylan added that the name change has been approved by the Registrar of Companies in India and that it intends to retain the Matrix name for its institutional antiretroviral (ARV) franchise.

Advertisement